The Protecting Access to Medicare Act (PAMA) requires that physicians ordering advanced imaging exams consult Appropriate Use Criteria (AUC) through a qualified Clinical Decision Support Mechanism (qCDSM). This year’s MPFS Proposed Rule (the third of four rule making cycles) provides important implementation details related to the AUC provisions of PAMA.
January 1, 2020 remains the formal start of the program. From this date forward, healthcare providers must consult a qCDSM when ordering advanced imaging tests furnished under Medicare Part B. Under the program, consultations must occur across all advanced imaging, and evidence of consultation must be included on all claims.
CareSelect Imaging is the most comprehensive CDS solution available for advanced imaging and is fully qualified under PAMA. Our CareSelect Imaging solution delivers AUC authored by leading medical specialty societies at the point-of-care, empowering enterprise-wide quality improvement efforts and ensuring compliance with PAMA AUC consultation requirements.